These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38490364)
41. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. Teo JY; Allen JC; Ng DC; Choo SP; Tai DW; Chang JP; Cheah FK; Chow PK; Goh BK HPB (Oxford); 2016 Jan; 18(1):7-12. PubMed ID: 26776845 [TBL] [Abstract][Full Text] [Related]
42. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987 [TBL] [Abstract][Full Text] [Related]
43. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Edeline J; Lenoir L; Boudjema K; Rolland Y; Boulic A; Le Du F; Pracht M; Raoul JL; Clément B; Garin E; Boucher E Ann Surg Oncol; 2013 Aug; 20(8):2518-25. PubMed ID: 23494107 [TBL] [Abstract][Full Text] [Related]
44. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study. Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030 [TBL] [Abstract][Full Text] [Related]
45. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma. Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889 [TBL] [Abstract][Full Text] [Related]
46. Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation. Gordon AC; Gupta AN; Gabr A; Thornburg BG; Kulik LM; Ganger DR; Maddur H; Flamm SL; Boike JR; Moore CM; Borja-Cacho D; Christopher DA; Katariya NN; Ladner DP; Caicedo-Ramirez JC; Riaz A; Salem R; Lewandowski RJ J Vasc Interv Radiol; 2021 Feb; 32(2):211-219. PubMed ID: 33349507 [TBL] [Abstract][Full Text] [Related]
47. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres. Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356 [TBL] [Abstract][Full Text] [Related]
48. Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study. Salem R; Johnson GE; Kim E; Riaz A; Bishay V; Boucher E; Fowers K; Lewandowski R; Padia SA Hepatology; 2021 Nov; 74(5):2342-2352. PubMed ID: 33739462 [TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant Radiation Lobectomy As an Alternative to Portal Vein Embolization in Hepatocellular Carcinoma. Gabr A; Polineni P; Mouli SK; Riaz A; Lewandowski RJ; Salem R Semin Nucl Med; 2019 May; 49(3):197-203. PubMed ID: 30954185 [TBL] [Abstract][Full Text] [Related]
58. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Garlipp B; de Baere T; Damm R; Irmscher R; van Buskirk M; Stübs P; Deschamps F; Meyer F; Seidensticker R; Mohnike K; Pech M; Amthauer H; Lippert H; Ricke J; Seidensticker M Hepatology; 2014 May; 59(5):1864-73. PubMed ID: 24259442 [TBL] [Abstract][Full Text] [Related]
59. Yttrium-90 Radioembolization for Hepatocellular Carcinoma with Portal Vein Invasion: Validation of the Milan Prognostic Score. Bargellini I; Scalise P; Boni G; Traino CA; Bozzi E; Lorenzoni G; Crocetti L; Cioni R J Vasc Interv Radiol; 2020 Dec; 31(12):2028-2032. PubMed ID: 33121865 [TBL] [Abstract][Full Text] [Related]
60. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial. Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA Trials; 2012 Aug; 13():144. PubMed ID: 22913492 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]